Compare BDX & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDX | HLN |
|---|---|---|
| Founded | 1897 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5B | 43.7B |
| IPO Year | 1995 | N/A |
| Metric | BDX | HLN |
|---|---|---|
| Price | $154.81 | $9.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $188.73 | N/A |
| AVG Volume (30 Days) | 2.1M | ★ 8.4M |
| Earning Date | 04-30-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.72% | 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $21,840,000,000.00 | N/A |
| Revenue This Year | N/A | $7.04 |
| Revenue Next Year | $2.22 | $4.58 |
| P/E Ratio | $115.46 | ★ $49.05 |
| Revenue Growth | ★ 8.24 | N/A |
| 52 Week Low | $153.18 | $8.71 |
| 52 Week High | $213.08 | $11.42 |
| Indicator | BDX | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 31.50 | 42.04 |
| Support Level | $153.75 | $9.60 |
| Resistance Level | $160.19 | $9.96 |
| Average True Range (ATR) | 3.26 | 0.15 |
| MACD | 0.89 | 0.00 |
| Stochastic Oscillator | 12.96 | 28.79 |
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.